Alkermes
ALKS
#3093
Rank
$4.87 B
Marketcap
$29.52
Share price
0.75%
Change (1 day)
-6.17%
Change (1 year)

Alkermes (ALKS) - Total assets

Total assets on the balance sheet as of September 2025 : $2.32 Billion USD

According to Alkermes's latest financial reports the company's total assets are $2.32 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alkermes - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$2.05 B-3.78%
2023-12-31$2.13 B8.77%
2022-12-31$1.96 B-2.99%
2021-12-31$2.02 B3.83%
2020-12-31$1.94 B7.99%
2019-12-31$1.80 B-1.07%
2018-12-31$1.82 B1.55%
2017-12-31$1.79 B4.1%
2016-12-31$1.72 B-6.97%
2015-12-31$1.85 B-3.3%
2014-12-31$1.91 B
2013-03-31$1.47 B2.44%
2012-03-31$1.43 B217.21%
2011-03-31$0.45 B-12.25%
2010-03-31$0.51 B-8.98%
2009-03-31$0.56 B-13.69%
2008-03-31$0.65 B15.42%
2007-03-31$0.56 B19.17%
2006-03-31$0.47 B40.81%
2005-03-31$0.33 B25.5%
2004-03-31$0.27 B5.6%
2003-03-31$0.25 B-27.02%
2002-03-31$0.35 B-10.46%
2001-03-31$0.39 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Acorda Therapeutics
ACOR
$81.57 M-96.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$96.88 B 4,059.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$192.81 B 8,177.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$208.73 B 8,860.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$114.45 B 4,813.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$39.85 B 1,610.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$152.32 B 6,438.89%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
$107.28 B 4,505.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland